NLRP3 and depressive symptom measurement: Upregulated HIF-1α/NLRP3 signaling in the peri-thalamic sites activated microglia and astrocytes, releasing pro-inflammatory cytokines and oxidative stress, leading to CPSP and comorbid anxiety and depression.